Memorial Day! 45% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s

Aptose Biosciences Earnings Calls

Q1 2025 Beat
-$2.61 (2.36%)
Release date May 12, 2025
EPS estimate -$2.67
EPS actual -$2.61
EPS Surprise 2.36%
Revenue estimate -
Revenue actual -
Q4 2024 Missed
-$43.24 (-3,473.55%)
Release date Mar 25, 2025
EPS estimate -$1.21
EPS actual -$43.24
EPS Surprise -3,473.55%
Revenue estimate -
Revenue actual -
Q3 2024 Missed
-$11.11 (-833.61%)
Release date Nov 08, 2024
EPS estimate -$1.19
EPS actual -$11.11
EPS Surprise -833.61%
Revenue estimate -
Revenue actual -
Q2 2024 Beat
-$12.91 (25.89%)
Release date Aug 08, 2024
EPS estimate -$17.42
EPS actual -$12.91
EPS Surprise 25.89%
Revenue estimate -
Revenue actual -

Last 4 Quarters for Aptose Biosciences

Below you can see how APTO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q2 2024 Beat
Release date Aug 08, 2024
Fiscal end date Jun 30, 2024
Price on release $0.555
EPS estimate -$17.42
EPS actual -$12.91
EPS surprise 25.89%
Date Price
Aug 02, 2024 $0.489
Aug 05, 2024 $0.414
Aug 06, 2024 $0.457
Aug 07, 2024 $0.499
Aug 08, 2024 $0.555
Aug 09, 2024 $0.513
Aug 12, 2024 $0.472
Aug 13, 2024 $0.475
Aug 14, 2024 $0.481
4 days before 13.50%
4 days after -13.33%
On release day -7.53%
Change in period -1.64%
Q3 2024 Missed
Release date Nov 08, 2024
Fiscal end date Sep 30, 2024
Price on release $0.385
EPS estimate -$1.19
EPS actual -$11.11
EPS surprise -833.61%
Date Price
Nov 04, 2024 $0.398
Nov 05, 2024 $0.383
Nov 06, 2024 $0.400
Nov 07, 2024 $0.389
Nov 08, 2024 $0.385
Nov 11, 2024 $0.381
Nov 12, 2024 $0.391
Nov 13, 2024 $0.380
Nov 14, 2024 $0.385
4 days before -3.22%
4 days after 0.0779%
On release day -1.17%
Change in period -3.14%
Q4 2024 Missed
Release date Mar 25, 2025
Fiscal end date Dec 31, 2024
Price on release $3.48
EPS estimate -$1.21
EPS actual -$43.24
EPS surprise -3,473.55%
Date Price
Mar 19, 2025 $3.81
Mar 20, 2025 $3.93
Mar 21, 2025 $3.69
Mar 24, 2025 $3.56
Mar 25, 2025 $3.48
Mar 26, 2025 $3.49
Mar 27, 2025 $3.70
Mar 28, 2025 $3.32
Mar 31, 2025 $3.15
4 days before -8.66%
4 days after -9.48%
On release day 0.287%
Change in period -17.32%
Q1 2025 Beat
Release date May 12, 2025
Fiscal end date Mar 31, 2025
Price on release $1.71
EPS estimate -$2.67
EPS actual -$2.61
EPS surprise 2.36%
Date Price
May 06, 2025 $1.71
May 07, 2025 $1.71
May 08, 2025 $1.71
May 09, 2025 $1.71
May 12, 2025 $1.71
May 13, 2025 $1.71
May 14, 2025 $1.71
May 15, 2025 $1.71
May 16, 2025 $1.71
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%

Aptose Biosciences Earnings History

Earnings Calendar

FAQ

When is the earnings report for APTO?
Aptose Biosciences (APTO) has scheduled its earnings report for Aug 06, 2025 after the markets close.

What is the APTO price-to-earnings (P/E) ratio?
APTO P/E ratio as of May 23, 2025 (TTM) is -0.170.

What is the APTO EPS forecast?
The forecasted EPS (Earnings Per Share) for Aptose Biosciences (APTO) for the first fiscal quarter 2025 is $.

What are Aptose Biosciences's retained earnings?
On its balance sheet, Aptose Biosciences reported retained earnings of $0 for the latest quarter ending Mar 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT APTOSE BIOSCIENCES
Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph...
GOLDEN STAR
Ticker Change Signal Date
UAA
$5.84
11.64% May 09
IIPR
$54.61
1.70% May 09
HBM
$7.41
14.44% May 05
PODD
$257.01
24.90% May 02
GT
$9.14
21.77% Mar 21

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE